 | | Vol. 12.13 – 5 April, 2023 |
| |
|
|
| Using genetically engineered and carcinogen-induced mouse models of intestinal neoplasia, scientists observed that impaired differentiation was a conserved event preceding cancer development.
[Science Advances] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The sialylated cancer IgG (SIA-cIgG)/c-Met/SOX2/SIA-cIgG signaling loop was highly active in stem-like cells from many epithelial cancers and was crucial for cancer stemness in vitro and in vivo.
[Cancer Research] |
|
|
|
| Researchers observed that the expression of thymocyte-expressed, positive selection-associated 1 (Tespa1) was markedly increased in hematopoietic stem cells after stress exposure.
[Leukemia] |
|
|
|
| Scientists described a unique translation regulatory axis enacted by reduced expression of miR-183 in breast CSCs, which they showed targeted the eIF2Bδ subunit of guanine nucleotide exchange factor eIF2B.
[Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Investigators developed a thiol-Michael addition injectable hydrogel further to capture glioblastoma/glioblastoma stem-like cells through CXCL12-mediated chemotaxis.
[Advanced Healthcare Materials] |
|
|
|
| Researchers showed that post-oncolytic HSV (oHSV) virotherapy-activated AKT signaling results in an enrichment of glioblastoma stem-like cell signatures in glioma.
[Molecular Therapy Oncolytics] |
|
|
|
| Investigators evaluated novel regulators of stem cell factor expression to identify novel therapeutic strategies that could target liver CSCs.
[International Journal Of Oncology] |
|
|
|
| A soft agar colony formation assay using polymerase chain reaction method was applied to evaluate tumorigencitiy of cells in cellular therapy products.
[Scientific Reports] |
|
|
|
| The authors established a novel approach to capture and cultivate circulating tumor cells (CTCs) using a microfilter device. Whole blood was filtered to isolate CTCs and cells captured on the microfilter were cultured in place.
[Oncology Reports] |
|
|
|
|
| Scientists summarize the characteristic features and functional mechanisms of CSC-derived exosomes/mesenchymal stem cell exosomes/cancer-associated fibroblast exosomes and their mutual impact on cancer progression and therapy resistance.
[Biochimie] |
|
|
|
|
| Merck announced that the US FDA has granted full approval to KEYTRUDA for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors that have progressed following prior treatment and who have no satisfactory alternative treatment options.
[Merck] |
|
|
|
|
| April 25 – 26, 2023
Boston, Massachusetts, United States |
|
|
|
|
|
| | University of Southern California – Los Angeles, California, United States |
|
|
|
| | University of Texas Health Science Center – San Antonio, Texas, United States |
|
|
|
| | Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| | University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
| | Columbia University – New York, New York, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Umbilical & Placental Cell News
